«Kidney Failure Chronic

Below is an extended Kidney Failure Chronic patents listing. Click here to return to the Kidney Failure Chronic main in depth entry.

Patents :
US Patent No.	Title
4264512	3-Deoxy-1.alpha.-hydroxy- and 3-deoxy-1.alpha.,25-dihydroxycholecalciferol and processes for the preparation thereof
6698431	Apparatus and method for supporting human body during itimate activity
6730678	Benzoylguanidine salt and hydrates thereof
6737423	Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
6753164	Nucleic acids encoding human serpin polypeptide HMCIS41
6770466	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
6825231	Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
6878806	Human secreted protein HTEEB42
6900033	Methods and compositions for modulating ACE-2 activity
6686369	.alpha.-hydrdroxylic acid derivatives, their production and use
6663829	Method and apparatus for reducing the degradation of heat sensitive components in medical substances during heat sterilization
6592865	Methods and compositions for modulating ACE-2 activity
5783576	Benzoyl guanidine derivatives, the preparation thereof and their use in pharmaceutical compositions
6103732	Carboxylic acid derivatives, their production and use
6114335	Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines
6323207	Benzoylguanidine derivatives
6358983	Heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists
6448248	Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
6509341	Carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists
6561996	Apparatus and method for in vivo hemodialysis
6905688	Albumin fusion proteins
6919433	Antibodies to protein HPMBQ91
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7344882	Polynucleotides encoding variants of the TRP channel family member, LTRPC3
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7381800	Antibodies to HBIMF63 polypeptide
7163797	50 human secreted proteins
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7109208	Visual function disorder improving agents
6926898	Albumin fusion proteins
6946134	Albumin fusion proteins
6951924	Antibodies against secreted protein HTEBYII
6958357	Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them
6982256	Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidi- ne in intravenous administration
6994857	Albumin fusion proteins
7026447	53 human secreted proteins
7091315	Protein HDPBQ71
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.